GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Classys 214150.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

25,550

-1.16%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩336.82bn

FY2016FY2025

Net income

₩131.94bn

FY2016FY2025

Free cash flow

₩144.68bn

FY2016FY2025

Shareholders' equity

₩552.97bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩336.82bn₩242.94bn₩180.12bn₩141.80bn₩100.60bn₩76.46bn₩81.13bn₩47.48bn₩34.87bn₩27.24bn
Gross profit₩261.09bn₩191.13bn₩140.45bn₩108.17bn₩77.85bn₩60.96bn₩63.91bn₩34.75bn₩24.17bn₩18.55bn
Research and development₩17.44bn₩12.62bn₩9.20bn₩4.43bn₩4.70bn₩3.12bn₩1.92bn₩1.53bn₩1.53bn₩1.08bn
Operating income₩170.60bn₩110.75bn₩89.62bn₩68.88bn₩51.71bn₩40.61bn₩41.71bn₩17.48bn₩10.80bn−₩55.3m
Net income₩131.94bn₩97.88bn₩74.23bn₩75.38bn₩43.80bn₩38.16bn₩33.39bn₩14.86bn−₩5.13bn₩80.9m
Diluted earnings per share2,019.421,494.241,157.701,170.31676.87589.79525.93236.96-84.8014.70

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩704.65bn₩608.38bn₩375.44bn₩331.41bn₩216.38bn₩137.53bn₩113.66bn₩75.68bn₩63.16bn₩12.01bn
Cash and short-term investments—₩158.04bn₩136.86bn₩111.58bn₩47.91bn₩67.62bn₩45.02bn₩16.47bn₩19.44bn₩11.95bn
Total liabilities₩152.98bn₩155.73bn₩91.94bn₩101.86bn₩52.63bn₩13.77bn₩25.74bn₩24.63bn₩28.07bn₩1.42bn
Debt₩62.77bn₩91.11bn₩65.63bn₩67.90bn₩35.81bn₩387.0m₩9.87bn₩15.44bn₩20.86bn₩1.38bn
Shareholders' equity₩552.97bn₩453.96bn₩283.50bn₩229.55bn₩163.74bn₩123.76bn₩87.92bn₩51.04bn₩35.09bn₩10.60bn
Shares outstanding65m66m64m64m65m65m63m63m60m6m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩163.94bn₩102.80bn₩64.63bn₩54.75bn₩36.37bn₩38.13bn₩39.03bn₩15.99bn₩8.60bn₩5.77bn
Capital spending−₩19.25bn−₩10.78bn−₩6.11bn−₩71.24bn−₩90.91bn−₩791.9m−₩6.19bn−₩14.77bn−₩31.71bn−₩166.4m
Free cash flow₩144.68bn₩92.02bn₩58.52bn−₩16.49bn−₩54.54bn₩37.33bn₩32.84bn₩1.22bn−₩23.11bn₩5.60bn
Dividends paid−₩16.83bn−₩12.80bn−₩7.47bn−₩4.27bn−₩3.88bn−₩2.96bn−₩867.6m−₩483.8m−₩483.8m−₩483.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩105.52bn₩87.18bn₩93.43bn₩83.00bn₩83.28bn₩77.11bn₩74.40bn₩59.41bn
Gross profit₩76.52bn₩65.05bn₩72.02bn₩63.72bn₩64.02bn₩61.33bn₩56.81bn₩46.60bn
Operating income₩43.94bn₩37.20bn₩51.19bn₩37.62bn₩43.01bn₩38.78bn₩24.11bn₩28.95bn
Net income₩28.37bn₩33.62bn₩42.64bn₩33.01bn₩26.47bn₩29.82bn₩28.72bn₩16.49bn
Diluted earnings per share434.92515.43653.80505.22404.20455.20438.40257.64
Cash from operations₩5.99bn₩9.47bn₩91.49bn₩19.18bn₩23.15bn₩30.12bn₩39.63bn₩13.15bn
Capital spending−₩4.67bn−₩2.84bn−₩2.13bn−₩6.20bn−₩3.49bn−₩7.44bn−₩3.40bn−₩2.15bn
Free cash flow₩1.33bn₩6.63bn₩89.36bn₩12.99bn₩19.65bn₩22.68bn₩36.24bn₩11.00bn
Total assets₩774.74bn₩799.84bn₩704.65bn₩654.40bn₩626.55bn₩631.90bn₩608.38bn₩433.67bn
Cash and short-term investments—————₩174.39bn₩158.04bn₩108.23bn
Debt₩5.58bn₩1.16bn₩62.77bn₩83.32bn₩78.28bn₩79.09bn₩15.64bn₩296.5m
Shareholders' equity₩549.53bn₩521.81bn₩552.97bn₩519.68bn₩496.15bn₩468.16bn₩453.96bn₩341.98bn

Financial ratios

Data as of 26 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin77.5%78.7%78.0%76.3%77.4%79.7%——
Operating margin50.7%45.6%49.8%48.6%51.4%53.1%——
Net margin39.2%40.3%41.2%53.2%43.5%49.9%——
Return on equity23.9%21.6%26.2%32.8%26.8%30.8%——
Return on assets18.7%16.1%19.8%22.7%20.2%27.8%——
Free cash flow yield——————2.2%1.5%
Revenue growth38.6%34.9%27.0%41.0%31.6%-5.8%——
Earnings growth34.8%31.9%-1.5%72.1%14.8%14.3%——
Current ratio3.69x1.82x6.35x4.08x4.36x6.17x——
Debt to equity0.11x0.03x0.22x0.28x0.21x0.00x——
Equity ratio78.5%74.6%75.5%69.3%75.7%90.0%——
Interest coverage70.48x54.27x45.76x26.39x555.73x240.42x——
R&D as a share of sales5.2%5.2%5.1%3.1%4.7%4.1%——
Buybacks as a share of market value——————-1.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue33.4%34.5%—
Operating income35.3%33.3%—
Net income20.5%28.2%114.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin78.0%77.7%77.8%—
Operating margin48.5%48.8%49.3%—
Net margin39.6%42.1%42.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings27.031.932.615.727.826.126.917.2-49.1135.7
Price to sales10.612.813.48.412.113.011.15.47.20.4

Dividends and splits

Per share, in the currency the company pays

Paid for 9 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023FY2021FY2020FY2019FY2018
Paid in the year1,257.00200.00116.0066.0060.0060.008.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.